Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00521027 · ClinicalTrials.gov registry record · Phase 4
Study Comparing VERSAJET With Conventional Surgical Procedures in the Removal of Unhealthy Tissue From Lower Limb Ulcers
A Phase 4 study, sponsored by Smith & Nephew.
- Completed
- Registry status
- Phase 4
- Development phase
- 46
- Enrollment target
NCT00521027 is a Phase 4 study that has completed, run by Smith & Nephew. The registered enrollment target is 46 participants.
The verdict
NCT00521027, a Phase 4 study, has completed, sponsored by Smith & Nephew.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 46 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the VERSAJET™ device with conventional surgical procedures (performed with a scalpel) in the debridement (removal of unhealthy tissue) of lower limb ulcers. It is hypothesised that the time taken to debride lower limb ulcers will be quicker with the VERSAJET™ device than with conventional surgical procedures.
Interventions
- DEVICE Versajet Hydrosurgery System
- PROCEDURE Conventional surgical debridement techniques
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2006-04 |
| Est. Completion | 2006-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00521027
The ClinicalTrials.gov registry entry for NCT00521027 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Smith & Nephew, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Versajet Hydrosurgery System is the first listed.
NCT00521027 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00521027 about?
NCT00521027 is a clinical study titled "Study Comparing VERSAJET With Conventional Surgical Procedures in the Removal of Unhealthy Tissue From Lower Limb Ulcers". The purpose of this study is to compare the VERSAJET™ device with conventional surgical procedures (performed with a scalpel) in the debridement (removal of unhealthy tissue) of lower limb ulcers. It is hypothesised that the time taken to debride lower limb ulcers will be quicker with the VERSAJET™...
What is the current status of trial NCT00521027?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 46 participants. The study started on 2006-04. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00521027?
The interventions under investigation include: Versajet Hydrosurgery System (DEVICE), Conventional surgical debridement techniques (PROCEDURE).
Who is sponsoring clinical trial NCT00521027?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.